Cancer genomes are the result of diverse mutation processes that have often accumulated over decades. Scientists have analyzed the molecular evolution of tumors after exposure to mutagenic chemicals.
Despite the significance of immune checkpoint inhibitors (ICIs) in solid tumor treatment, identifying ICI-sensitive populations remains a challenge. Mutations in DNA damage response (DDR) pathway ...
Hosted on MSN
Engineered enzymes enable precise control of mitochondrial DNA mutation levels in cells
Mitochondrial diseases affect approximately 1 in 5,000 people worldwide, causing debilitating symptoms ranging from muscle weakness to stroke-like episodes. Some of these conditions result from ...
Development of a methylation-based, tissue-free test for the detection of molecular residual disease by circulating tumor DNA.
Images depicting cells where TREX1 is properly localed (on the left) and where it has mutated and mislocalized in the nucleus (on the right). “It seems that accelerated DNA damage in RVCL causes the ...
A microfluidic device barely larger than a U.S. quarter and developed by a Rutgers University-led team can detect rare genetic mutations from a single drop of blood. A team led by Rutgers ...
In a step toward treating mitochondrial diseases, researchers at the University Medical Center Utrecht and their colleagues have used mitochondrial base editing (mtBE) to successfully edit harmful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results